HEADER SIGNALING PROTEIN 24-APR-23 8OUR TITLE CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 16 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DUAL LEUCINE ZIPPER BEARING KINASE,DLK,LEUCINE-ZIPPER COMPND 5 PROTEIN KINASE,ZPK,MAPK-UPSTREAM KINASE,MUK,MIXED LINEAGE KINASE; COMPND 6 EC: 2.7.11.25; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP3K12, ZPK; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS DLK, KINASE, INHIBITOR, SIGNALING PROTEIN, TRANSFERASE-INHIBITOR, KEYWDS 2 M3K12 EXPDTA X-RAY DIFFRACTION AUTHOR M.ZEBISCH,P.A.MCEWAN,J.J.BARKER,J.B.CROSS REVDAT 2 09-AUG-23 8OUR 1 JRNL REVDAT 1 26-JUL-23 8OUR 0 JRNL AUTH K.LE,M.J.SOTH,J.B.CROSS,G.LIU,W.J.RAY,J.MA,S.G.GOODWANI, JRNL AUTH 2 P.J.ACTON,V.BUGGIA-PREVOT,O.AKKERMANS,J.BARKER,M.L.CONNER, JRNL AUTH 3 Y.JIANG,Z.LIU,P.MCEWAN,J.WARNER-SCHMIDT,A.XU,M.ZEBISCH, JRNL AUTH 4 C.J.HEIJNEN,B.ABRAHAMS,P.JONES JRNL TITL DISCOVERY OF IACS-52825, A POTENT AND SELECTIVE DLK JRNL TITL 2 INHIBITOR FOR TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL JRNL TITL 3 NEUROPATHY. JRNL REF J.MED.CHEM. V. 66 9954 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37436942 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00788 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 17948 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1001 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1295 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 76 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2115 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 122 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.13000 REMARK 3 B22 (A**2) : -1.53000 REMARK 3 B33 (A**2) : 2.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.200 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.181 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.163 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.315 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2250 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2170 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3076 ; 1.885 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5011 ; 0.954 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 278 ; 6.163 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;36.605 ;23.646 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 387 ;15.950 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;16.059 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 335 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2507 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 516 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1070 ; 1.158 ; 1.316 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1069 ; 1.149 ; 1.314 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1338 ; 1.913 ; 1.963 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1339 ; 1.913 ; 1.965 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1180 ; 1.513 ; 1.525 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1181 ; 1.512 ; 1.525 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1726 ; 2.470 ; 2.204 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2706 ; 5.531 ;11.289 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2707 ; 5.530 ;11.292 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 118 A 396 REMARK 3 ORIGIN FOR THE GROUP (A): 6.3885 2.2951 22.1920 REMARK 3 T TENSOR REMARK 3 T11: 0.0144 T22: 0.0901 REMARK 3 T33: 0.0254 T12: 0.0040 REMARK 3 T13: -0.0132 T23: 0.0284 REMARK 3 L TENSOR REMARK 3 L11: 2.0277 L22: 1.6405 REMARK 3 L33: 1.5483 L12: 0.2470 REMARK 3 L13: 0.4378 L23: 0.8622 REMARK 3 S TENSOR REMARK 3 S11: -0.0095 S12: 0.0650 S13: 0.0596 REMARK 3 S21: -0.0175 S22: 0.0146 S23: 0.0689 REMARK 3 S31: 0.0406 S32: -0.0181 S33: -0.0051 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8OUR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-APR-23. REMARK 100 THE DEPOSITION ID IS D_1292128531. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.2.8 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18960 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 32.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.90200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THIN PLATES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2 M MAGNESIUM ACETATE, REMARK 280 AND 0.1 M HEPES/NAOH PH 7.5-7.9, PH 7.7, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.62050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 112 REMARK 465 GLY A 113 REMARK 465 SER A 114 REMARK 465 GLU A 115 REMARK 465 ASP A 116 REMARK 465 LEU A 117 REMARK 465 THR A 257 REMARK 465 SER A 258 REMARK 465 LYS A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 SER A 262 REMARK 465 ASP A 263 REMARK 465 LYS A 264 REMARK 465 SER A 265 REMARK 465 THR A 266 REMARK 465 LYS A 267 REMARK 465 MET A 268 REMARK 465 SER A 269 REMARK 465 PHE A 270 REMARK 465 ALA A 271 REMARK 465 ILE A 397 REMARK 465 LYS A 398 REMARK 465 SER A 399 REMARK 465 GLU A 400 REMARK 465 GLY A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASN A 404 REMARK 465 SER A 405 REMARK 465 HIS A 406 REMARK 465 HIS A 407 REMARK 465 HIS A 408 REMARK 465 HIS A 409 REMARK 465 HIS A 410 REMARK 465 HIS A 411 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 280 CD GLU A 280 OE1 0.070 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 215 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 185 43.54 -94.57 REMARK 500 ARG A 235 -18.11 86.42 REMARK 500 ARG A 235 -17.89 86.25 REMARK 500 ASP A 236 41.84 -143.12 REMARK 500 REMARK 500 REMARK: NULL DBREF 8OUR A 115 402 UNP Q12852 M3K12_HUMAN 115 402 SEQADV 8OUR MET A 112 UNP Q12852 INITIATING METHIONINE SEQADV 8OUR GLY A 113 UNP Q12852 EXPRESSION TAG SEQADV 8OUR SER A 114 UNP Q12852 EXPRESSION TAG SEQADV 8OUR GLY A 403 UNP Q12852 EXPRESSION TAG SEQADV 8OUR ASN A 404 UNP Q12852 EXPRESSION TAG SEQADV 8OUR SER A 405 UNP Q12852 EXPRESSION TAG SEQADV 8OUR HIS A 406 UNP Q12852 EXPRESSION TAG SEQADV 8OUR HIS A 407 UNP Q12852 EXPRESSION TAG SEQADV 8OUR HIS A 408 UNP Q12852 EXPRESSION TAG SEQADV 8OUR HIS A 409 UNP Q12852 EXPRESSION TAG SEQADV 8OUR HIS A 410 UNP Q12852 EXPRESSION TAG SEQADV 8OUR HIS A 411 UNP Q12852 EXPRESSION TAG SEQRES 1 A 300 MET GLY SER GLU ASP LEU TRP GLU VAL PRO PHE GLU GLU SEQRES 2 A 300 ILE LEU ASP LEU GLN TRP VAL GLY SER GLY ALA GLN GLY SEQRES 3 A 300 ALA VAL PHE LEU GLY ARG PHE HIS GLY GLU GLU VAL ALA SEQRES 4 A 300 VAL LYS LYS VAL ARG ASP LEU LYS GLU THR ASP ILE LYS SEQRES 5 A 300 HIS LEU ARG LYS LEU LYS HIS PRO ASN ILE ILE THR PHE SEQRES 6 A 300 LYS GLY VAL CYS THR GLN ALA PRO CYS TYR CYS ILE LEU SEQRES 7 A 300 MET GLU PHE CYS ALA GLN GLY GLN LEU TYR GLU VAL LEU SEQRES 8 A 300 ARG ALA GLY ARG PRO VAL THR PRO SER LEU LEU VAL ASP SEQRES 9 A 300 TRP SER MET GLY ILE ALA GLY GLY MET ASN TYR LEU HIS SEQRES 10 A 300 LEU HIS LYS ILE ILE HIS ARG ASP LEU LYS SER PRO ASN SEQRES 11 A 300 MET LEU ILE THR TYR ASP ASP VAL VAL LYS ILE SER ASP SEQRES 12 A 300 PHE GLY THR SER LYS GLU LEU SER ASP LYS SER THR LYS SEQRES 13 A 300 MET SER PHE ALA GLY THR VAL ALA TRP MET ALA PRO GLU SEQRES 14 A 300 VAL ILE ARG ASN GLU PRO VAL SER GLU LYS VAL ASP ILE SEQRES 15 A 300 TRP SER PHE GLY VAL VAL LEU TRP GLU LEU LEU THR GLY SEQRES 16 A 300 GLU ILE PRO TYR LYS ASP VAL ASP SER SER ALA ILE ILE SEQRES 17 A 300 TRP GLY VAL GLY SER ASN SER LEU HIS LEU PRO VAL PRO SEQRES 18 A 300 SER SER CYS PRO ASP GLY PHE LYS ILE LEU LEU ARG GLN SEQRES 19 A 300 CYS TRP ASN SER LYS PRO ARG ASN ARG PRO SER PHE ARG SEQRES 20 A 300 GLN ILE LEU LEU HIS LEU ASP ILE ALA SER ALA ASP VAL SEQRES 21 A 300 LEU SER THR PRO GLN GLU THR TYR PHE LYS SER GLN ALA SEQRES 22 A 300 GLU TRP ARG GLU GLU VAL LYS LEU HIS PHE GLU LYS ILE SEQRES 23 A 300 LYS SER GLU GLY THR GLY ASN SER HIS HIS HIS HIS HIS SEQRES 24 A 300 HIS HET W38 A 501 31 HETNAM W38 5-[1-(3-MORPHOLIN-4-YL-1-BICYCLO[1.1.1]PENTANYL)-2- HETNAM 2 W38 PROPAN-2-YL-IMIDAZOL-4-YL]-3-(TRIFLUOROMETHYLOXY) HETNAM 3 W38 PYRIDIN-2-AMINE FORMUL 2 W38 C21 H26 F3 N5 O2 FORMUL 3 HOH *122(H2 O) HELIX 1 AA1 PRO A 121 ILE A 125 5 5 HELIX 2 AA2 ASP A 156 ASP A 161 5 6 HELIX 3 AA3 ILE A 162 ARG A 166 5 5 HELIX 4 AA4 GLN A 197 ALA A 204 1 8 HELIX 5 AA5 THR A 209 HIS A 230 1 22 HELIX 6 AA6 LYS A 238 PRO A 240 5 3 HELIX 7 AA7 THR A 273 MET A 277 5 5 HELIX 8 AA8 ALA A 278 ARG A 283 1 6 HELIX 9 AA9 GLU A 289 GLY A 306 1 18 HELIX 10 AB1 ASP A 314 SER A 324 1 11 HELIX 11 AB2 PRO A 336 TRP A 347 1 12 HELIX 12 AB3 LYS A 350 ARG A 354 5 5 HELIX 13 AB4 SER A 356 SER A 373 1 18 HELIX 14 AB5 PRO A 375 GLU A 395 1 21 SHEET 1 AA1 5 LEU A 126 GLY A 134 0 SHEET 2 AA1 5 GLY A 137 PHE A 144 -1 O LEU A 141 N GLN A 129 SHEET 3 AA1 5 GLU A 147 LYS A 153 -1 O GLU A 147 N PHE A 144 SHEET 4 AA1 5 CYS A 187 GLU A 191 -1 O MET A 190 N ALA A 150 SHEET 5 AA1 5 PHE A 176 CYS A 180 -1 N GLY A 178 O LEU A 189 SHEET 1 AA2 2 MET A 242 ILE A 244 0 SHEET 2 AA2 2 VAL A 250 ILE A 252 -1 O LYS A 251 N LEU A 243 CISPEP 1 ALA A 183 PRO A 184 0 2.80 CRYST1 57.143 39.241 59.745 90.00 104.40 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017500 0.000000 0.004493 0.00000 SCALE2 0.000000 0.025484 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017281 0.00000